| Literature DB >> 35571242 |
Wanxiang Hu1, Menghua Chen2, Wenyan Wang2, Fan Huang1, Xinyue Tian1, Lu Xie1.
Abstract
Background: In cardiac accident/cardiopulmonary resuscitation (CA/CPR) rat model, oxidative stress occurs during cerebral ischemia/reperfusion injury (CIRI), and antioxidative treatment has a neuroprotective effect. The antioxidant capabilities of pomelo peel essential oil (PPEO) have mostly been investigated in vitro, with little convincing data in vivo, particularly whether PPEO has a neuroprotective role against CIRI.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35571242 PMCID: PMC9098344 DOI: 10.1155/2022/8279851
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 7.310
Figure 1Gas chromatogram spectrum of PPEO from Rongxian in Guangxi province.
Volatile constituents of essential oil of pomelo peel from Rongxian in Guangxi province.
| No. | Name of compound | Mol weight (amu) | Molecular formula | Relative content (%) |
|---|---|---|---|---|
| 1 | 1-Butanol, 2-ethyl- | 102.104 | C6H14O | 0.37 |
| 2 |
| 136.125 | C10H16 | 0.61 |
| 3 | D-Limonene | 136.125 | C10H16 | 50.67 |
| 4 | 2-Furanmethanol, 5-ethenyltetrahydro-.alpha.,.alpha.,5-trimethyl-, cis- | 170.131 | C10H18O2 | 0.50 |
| 5 | Benzene, 1-methyl-4-(1-methylethenyl)- | 132.094 | C10H12N2O2 | 1.71 |
| 6 | 1,6-Octadien-3-ol, 3,7-dimethyl- | 154.136 | C10H18O | 5.03 |
| 7 | Cyclohexane, 2-ethenyl-1,1-dimethyl-3-methylene- | 150.141 | C10H18 | 0.63 |
| 8 | 2-Cyclohexen-1-ol, 1-methyl-4-(1-methylethenyl)-, trans- | 152.12 | C10H16O | 0.40 |
| 9 | Limonene oxide, cis- | 152.12 | C10H16O | 4.51 |
| 10 | Cyclohexanol, 1-methyl-4-(1-methylethenyl)- | 154.136 | C10H18O | 0.54 |
| 11 | Bicyclo[3.3.0]oct-2-en-7-one, 6-methyl- | 136.089 | C8H9ClO | 0.37 |
| 12 | 3-Cyclohexen-1-ol, 4-methyl-1-(1-methylethyl)- | 154.136 | C10H18O | 1.56 |
| 13 | Ethanone, 1-(4-methylphenyl)- | 134.073 | C9H10O | 0.35 |
| 14 | 3,9-Epoxy-p-mentha-1,8 (10)-diene | 150.104 | C10H14O | 0.65 |
| 15 | 1R- | 136.125 | C10H16 | 4.01 |
| 16 | Santolina triene | 136.125 | C10H16 | 2.58 |
| 17 | 2-Cyclohexen-1-ol, 2-methyl-5-(1-methylethenyl)-, cis- | 152.12 | C10H16O | 2.34 |
| 18 | 2,6-Octadienal, 3,7-dimethyl-, (Z)- | 152.12 | C10H16O | 1.67 |
| 19 | 2-Cyclohexen-1-ol, 2-methyl-5-(1-methylethenyl)-, trans- | 152.12 | C10H16O | 1.88 |
| 20 | 2-Cyclohexen-1-one, 2-methyl-5-(1-methylethenyl)-, (S)- | 150.104 | C10H16O | 2.88 |
| 21 | 2,6-Octadien-1-ol, 3,7-dimethyl- | 154.136 | C10H18O | 0.97 |
| 22 | 2,6-Octadienal, 3,7-dimethyl- | 152.12 | C10H16O | 0.74 |
| 23 | 2-Cyclohexen-1-one, 3-methyl-6-(1-methylethenyl)- | 150.104 | C10H14O | 0.81 |
| 24 | 1-Cyclohexene-1-methanol, 4-(1-methylethenyl)- | 152.12 | C10H16O | 0.67 |
| 25 | 4-(1-Hydroxyethyl)benzaldehyde | 150.068 | C9H10O2 | 0.64 |
| 26 | 1,3,3-Trimethyl-2-hydroxymethyl-3,3-dimethyl-4-(3-methylbut-2-enyl)-cyclohexene | 222.198 | 0.43 | |
| 27 | 1,2-Cyclohexanediol, 1-methyl-4-(1-methylethenyl)- | 170.131 | C10H18O2 | 0.34 |
| 28 | Cyclopropanecarboxaldehyde, 2-methyl-2-(4-methyl-3-pentenyl)-, trans-(.+-.)- | 166.136 | C11H20O | 0.34 |
| 29 | Bicyclo[3.1.1]heptane, 6,6-dimethyl-2-methylene-, (1S)- | 136.125 | C10H16 | 1.96 |
| 30 | 2,6-Octadien-1-ol, 3,7-dimethyl-, acetate, (E)- | 196.146 | C12H20O2 | 2.82 |
| 31 | Cyclohexane, 1-ethenyl-1-methyl-2,4-bis(1-methylethenyl)-, [1S-(1.alpha.,2.beta.,4.beta.)]- | 204.188 | C15H24 | 0.31 |
| 32 | Caryophyllene | 204.188 | C15H24 | 1.53 |
| 33 | Naphthalene, 1,2,3,5,6,7,8,8a-octahydro-1,8a-dimethyl-7-(1-methylethenyl)-, [1R-(1.alpha.,7.beta.,8a.alpha.)]- | 204.188 | C15H24 | 0.79 |
| 34 | Naphthalene, 1,2,4a,5,8,8a-hexahydro-4,7-dimethyl-1-(1-methylethyl)-, (1.alpha.,4a.beta.,8a.alpha.)-(.+/-.)- | 204.188 | C15H24 | 0.63 |
| 35 | 2(3H)-Naphthalenone, 4,4a,5,6,7,8-hexahydro-4,4a-dimethyl-6-(1-methylethenyl)-, [4R-(4.alpha.,4a.alpha.,6.beta.)]- | 218.167 | C15H22O | 2.82 |
Figure 2(a) Neurological function scores at 24 h after CA/CPR. All datas were represented as mean ± standard deviation. (b) Morphological changes of neurons by Nissl staining, the bar graph of the number and IOD of Nissl bodies, magnification ×40; #compared to the sham group P < 0.05 and ∗compared to the CPR+NS group P < 0.05. (c) Morphological changes of mitochondria and nucleus observed by transmission electron microscopy (TEM). Black arrows showed the membrane of mitochondria. Compared to the sham group, the structure of mitochondria membrane was disorganized even ruptured in the model group. Scale bar: 2 μm (left) or 200 nm (right).
Figure 3(a) Immunohistochemistry staining for SLC7A11 and GPX4 in cortex neurons (400x) and statistical analysis bar graph in each group, respectively. SLC7A11 or GPX4-positive neuron was stained brown. The data were expressed as the mean ± SEM (n = 5 per group). #P < 0.05 and ##P < 0.01 compared to the sham group; ∗P < 0.05 and ∗∗P < 0.01 compared to the NS group. (b and d) Western blot analysis of GPX4 and SLC7A11 protein expression in vivo and in vitro. The data were expressed as the mean ± SEM (n = 5 per group). #P < 0.05 compared to the sham group; ∗P < 0.05 compared to the NS group. (c) Measurement of the level of GSH in different groups or SH-SY5Y cells. #P < 0.05 compared to the sham group and ∗P < 0.05 or ∗∗P<0.01 compared to the NS group. (e) GSH content assay in SH-SY5Y cells. #P < 0.05 or ##P < 0.01 compared to the control group and ∗∗P<0.01 compared to the OGD+PPEO group.
Figure 4(a and b) Measurement of the level of MDA and total iron in different groups. (c) Flow cytometry assay of intracellular ROS in SH-SY5Y cells. (d) Immunofluorescence double staining of ACSL4 and Gpx4 (scale bar: 20 μm). #P < 0.05 or ##P < 0.01 compared to the sham group and ∗P < 0.05 or ∗∗P < 0.01 compared to the NS group. The data were expressed as the mean ± SEM.
Figure 5Immunofluorescence images of Nrf2-positive protein in nucleus after OGD/R or PPEO treatment. Scale bar: 50 μm.
Figure 6Many targets involved in the modulating mechanism of PPEO on ferroptosis in CIRI.
Figure 7Mechanism of PPEO against CIRI through Nrf2-SystemXc−-GSH-GPX4 axis.